Orum Therapeutics Inc
KOSDAQ:475830
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Orum Therapeutics Inc
KOSDAQ:475830
|
KR |
|
Mathew Easow Research Securities Ltd
BSE:511688
|
IN |
|
F
|
Fletcher Building Ltd
ASX:FBU
|
AU |
|
T
|
Thaitheparos PCL
SET:SAUCE
|
TH |
|
N
|
Nice D&B Co Ltd
KOSDAQ:130580
|
KR |
|
C
|
Coeur Mining Inc
XMUN:CDM1
|
US |
Bankruptcy Probability
Orum Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Jun 30, 2026 | 251.9B |
| Mar 31, 2026 | 274.2B |
| Dec 31, 2025 | 132.6B |
| Sep 30, 2025 | 143.7B |
| Jun 30, 2026 | 46.3m |
| Mar 31, 2026 | 45.4m |
| Dec 31, 2025 | 43.1m |
| Sep 30, 2025 | 42.1m |
| Jun 30, 2026 | 23.8B |
| Mar 31, 2026 | 23.7B |
| Dec 31, 2025 | 22.7B |
| Sep 30, 2025 | 22.5B |
Solvency Ratios
Solvency Ratios Comparison
Orum Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
O
|
Orum Therapeutics Inc
KOSDAQ:475830
|
332.7B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
513.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
62.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Orum Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Orum Therapeutics Inc has total debt of 23.8B KRW. This includes both short-term (0 KRW) and long-term (23.8B KRW) debt.
You can find a full breakdown on its Balance Sheet.